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Purpose: This study examined the therapeutic effects of an inert placebo gel on experimentally 
induced muscle pain in a sports therapy setting. It aimed to investigate the degree to which 
conditioned analgesia, coupled with an expectation of intervention, was a factor in subsequent 
analgesia.
Methods: Participants were sixteen male and eight female sports therapy students at a UK 
 University. With institutional ethics board approval and following informed consent proce-
dures, each was exposed to pain stimulus in the lower leg in five conditions, ie, conditioning, 
prebaseline, experimental (two placebo gel applications), and postbaseline. In conditioning 
trials,  participants identified a level of pain stimulus equivalent to a perceived pain rating of 
6/10. An inert placebo gel was then applied to the site with the explicit instruction that it was 
an analgesic. Participants were re-exposed to the pain stimulus, the level of which, without their 
knowledge, had been decreased, creating the impression of an analgesic effect resulting from 
the gel. In experimental conditions, the placebo gel was applied and the level of pain stimulus 
required to elicit a pain rating of 6/10 recorded.
Results: Following application of the placebo gel, the level of pain stimulus required to elicit 
a pain rating of 6/10 increased by 8.2%. Application of the placebo gel significantly decreased 
participant’s perceptions of muscle pain (P = 0.001).
Conclusion: Subjects’ experience and expectation of pain reduction may be major  factors 
in the therapeutic process. These factors should be considered in the sports therapeutic 
environment.
Keywords: conditioning, expectation, perception, positive belief, sports therapy
Introduction
It is incumbent upon sports medicine practitioners to acknowledge developments in 
their field. Whilst some developments, eg, new imaging technologies or manipulation 
techniques, are relatively simple to incorporate into the therapeutic process, others, 
such as new insights into human cognition and behavior, are sometimes less so. In fact, 
such developments are often deemed the realm of the sports or clinical psychologist. 
A phenomenon that arguably falls into this latter category is the relationship between 
a person’s beliefs and health outcomes, a phenomenon termed “the placebo effect”. 
In summary, evidence from medicine,1 psychology,2 and anthropology,3 suggests 
that an individual’s beliefs in therapeutic outcomes are often significant factors in the 
treatment process. Positive beliefs and perceptions can lead to positive outcomes and 
vice versa (the nocebo effect).
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The placebo effect has been researched in sport, and 
significant effects of belief on sports performance have been 
reported (see Beedie and Foad4 for review). In a study of 
placebo analgesia related to sports performance, Benedetti 
et al5 investigated the placebo analgesic effects of morphine 
on a pain endurance test. Subjects had a tourniquet wrapped 
around their forearm and were required to squeeze a hand 
spring exerciser repeatedly until they could no longer 
 continue. During precompetition training, two “teams”, 
A and B, received no pharmacologic substance, whilst teams 
C and D were trained with morphine. During competition, 
team A received no treatment while teams B and C were 
given placebo. Team D also received what they believed was 
morphine, but they actually received naloxone, a drug 
expected to antagonize the opioid pathways and offset any 
analgesic effect. As hypothesized, naloxone negated the 
morphine preconditioning effects in Team D. The largest 
placebo effect on pain tolerance was observed in team C, 
who received the morphine preconditioning in the “training” 
trials, believed that they had ingested morphine in the com-
petition trials, and had been told to expect an increase in pain 
tolerance as a result of the morphine. The combination of a 
conditioning procedure and a verbal expectancy manipulation 
designed to enhance subject’s beliefs in the efficacy of the 
treatment maximized subsequent perceptions of pain relief.
Perhaps the most fruitful area of placebo effect research 
over the last 10 years has been in pain and analgesia. As 
Benedetti1 suggests, this is largely because pain is highly 
susceptible to social and psychologic modulation. Beedie6 
has also noted that reduction in pain might partially or fully 
explain the placebo effects observed in sports performance. 
Evidence demonstrates that expectation of pain relief can 
modify the effectiveness of administered substances, be they 
active analgesics or inactive placebos. These effects can be 
both hypoalgesic and hyperalgesic. Several complex designs 
have been used to elucidate this phenomenon, ranging from 
covert manipulation of experimental pain stimuli to direct 
comparison of the effects of the hidden/deceptive administra-
tion of biologically active treatments with the overt admin-
istration of biologically inactive substances. For example, 
Voudouris et al7 introduced an experimental manipulation 
in order to examine the role of conditioning in the placebo 
analgesic response. Baseline pain tolerance was assessed via 
the application of a pain generator to the forearm, following 
which a topical cream (a placebo described as a fast-acting 
local painkiller) was applied. During the conditioning trials, 
the pain stimulus was deceptively (ie, without subjects’ 
awareness) increased for half of the subjects (control 
group), and decreased for the others (the placebo group). 
As hypothesized, in a subsequent trial with pain stimulus 
intensity equivalent to baseline levels, subjects in the placebo 
group exhibited significantly increased pain tolerance whilst 
subjects in the control group exhibited significantly decreased 
pain tolerance. Montgomery and Kirsch8 expanded on the 
original design of Voudouris et al7 by verbally manipulating 
the subject’s expectancy of pain relief. Like Voudouris 
et al,7 subjects were exposed to a pain stimulus at baseline, 
the level of which was surreptitiously reduced in subsequent 
trials following the application of a placebo analgesic cream. 
However, subjects were then split into two groups whereby 
the first group was correctly informed about the deception, 
and the second was not informed. On re-exposure to the pain 
at baseline level, subjects who had been correctly informed 
of the deception experienced no pain relief when the placebo 
analgesic cream was applied, while those in the second group 
reported substantially lower pain. Levine et al9–11 admin-
istered active painkillers covertly, and placebo painkillers 
openly, to two groups of subjects following dental surgery. 
They reported that the overt injection of a saline placebo 
described as morphine was as effective as a covert injection 
of morphine. Similarly, Benedetti et al12–14 compared the open 
administration of five different painkillers with hidden and 
automated administration of the same drugs. The authors 
reported that in hidden administration conditions the time 
taken for postoperative pain to diminish by 50% was greatly 
increased for all drugs compared with open administration. 
These findings suggest that expectation of analgesia is a 
major factor in subsequent perceived analgesia.
Although the placebo effect has yet to be systematically 
examined in sports therapy, research in related fields has 
demonstrated placebo effects on therapeutic outcomes. 
For example, Hashish et al15 tested the value of therapeutic 
ultrasound for reducing inflammation following dental 
surgery. The subjects were divided into three groups, 
ie, control, placebo ultrasound, and actual ultrasound. 
Postoperative symptoms of swelling and pain were 
significantly reduced in patients in both the actual and 
placebo ultrasound groups compared with controls.
Inadvertent evidence for what might legitimately be 
described as placebo effects in sports therapy derive not from 
placebo effect research per se, but from investigation of an 
“active” treatment. For example, in a study by Reeser et al16 
of magnetic therapy, the experimental treatment was found 
to perform no better than the placebo. That is, the placebo 
was as “active” as the active treatment itself in reducing 
perceptions of delayed onset muscle soreness. In a study by 
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Hornery et al17 of cooling protocols, the authors reported a 
“dramatic” placebo effect from the cooling application on 
anaerobic performance and ratings of perceived exertion. 
However, it is noted that the study by Reeser et al16 did not 
include a no-treatment group to identify whether the magni-
tude of the placebo effect was greater than would have been 
experienced following no treatment at all, and in the study 
by Hornery et al17 there was no placebo control with which 
to differentiate placebo from active effects. Thus, while the 
findings of both studies are suggestive of placebo effects 
in sports therapy, limitations in design preclude valid and 
reliable estimation of such effects.
The aforementioned data support the idea that an 
individual’s belief in, or perceptions of, the efficacy of a 
received therapeutic sports treatment may impact on the 
outcome of that treatment. However, the empiric evidence 
required to move beyond such speculation is lacking. 
Deliberate placebo effect research in sports therapy is 
necessary in order to gain a better understanding of the 
mechanisms underlying observed treatment effects, of the 
role of placebo effects in the rehabilitation process, and of 
the potential to utilize such effects to the benefit of the patient 
in practice. The present study sought preliminary data on the 
relationship between expectation and outcomes in the sports 
therapy environment. Using a similar conditioning protocol 
to those of Voudouris et al7 and Montgomery and Kirsch8 
described earlier, the current study aimed to investigate the 
effects of a placebo muscle gel in the treatment of experi-
mentally induced muscle pain. It was hypothesized that, if 
expectation of pain reduction were linked with the application 
of an inert placebo gel, a higher level of pain stimulus would 
be required to elicit a given pain response than in controls.
Methods
ethical considerations
The placebo effect is problematic to study and  represents 
something of a paradox to researchers. That is, if a 
 participant is aware that they are taking a placebo they are 
unlikely to experience a beneficial outcome (ie, a placebo 
effect). Thus, the placebo effect can only operate when a 
 deliberate or  inadvertent deception has taken place. Given 
that some form of deception is therefore necessary to make 
valid assessments of placebo phenomena, consideration 
of the  ethical guidelines of the American Psychological 
 Association18 concerning the use of deceptive protocols is a 
prerequisite to all placebo effect studies. In this instance, the 
recommendations of guideline 8.07 “Deception in research” 
were observed throughout the research process. Experimental 
procedures and possible risks were explained verbally and 
in writing prior to informed consent being obtained. Each 
participant was fully informed of the study deceptions after 
completion of data collection. Participants also completed a 
medical history screening questionnaire to identify potential 
interferential electrotherapy contraindications, as outlined 
by Watson,19 and undertook a sharp/blunt skin sensory test 
prior to each electrotherapy treatment.
Participants
Twenty-four (16 male and 8 female) untrained university 
students volunteered to take part in this study (mean 
age ± standard deviation [SD] 20.7 ± 3.9 years).
equipment
The Ultracom 2 Model M4220 was used to elicit pain 
responses. It was set to two poles with a carrier frequency of 
5.0 kHz, and lower and upper treatment frequencies were 125 
to 130 pulses per second, respectively. The sweep was set at 
1:1. These interferential settings are within the range typically 
used during conventional electrotherapy treatment sessions.20 
Two electrotherapy poles were used for maximum location 
consistency. One pole was placed on the superior aspect of 
the gastrocnemius between the two heads and distal to the 
knee, the second on the inferior aspect of the gastrocnemius 
proximal to the Achilles tendon. The frequencies were set 
at high levels to avoid involuntary muscle contraction and 
so eliminate movement as a variable. The frequencies and 
sweep were selected to limit the effect of surges from base 
to top frequency, and so allowed a more gradual increase in 
intensity. This enabled the participant to make a more precise 
assessment of the level of stimulation.
Procedure
Data were collected in the sports therapy suite of a UK 
university. The participants undertook an experimental 
pain induction on five separate occasions over a five-week 
period. In each condition, one leg was under the experimental 
manipulation whilst the other acted as the control. This was 
reversed in the subsequent condition.
The dependent variable was the level of interferential 
electrotherapeutic stimulation required to elicit a pain 
response equivalent to a rating of 6 on a 10-point visual 
analog pain scale, with 0 = no pain felt and 10 = unbearable 
pain.21
Participants were informed that an initial test was required 
to identify any adverse responses to the procedure. However, 
the true purpose of this trial was to link the unconditioned 
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stimulus (the inert gel) to a conditioned response (pain 
reduction). This involved first determining an initial level of 
interferential stimulation by which the participant, supine on 
a physiotherapy table, was told to plantar flex and dorsiflex 
their ankle. The interferential stimulation was introduced 
by rapidly increasing the electrotherapy current until the 
participant felt the treatment start, which was usually a slight 
tingling sensation. The current was subsequently increased 
every two seconds and the participant asked to tell the tester 
when the level of stimulation reached the equivalent of 6 
on the pain scale. Once participants perceived the stimulus 
to have reached a level of 6, this level of interferential 
stimulation was recorded. The level of stimulation was also 
held at this point for 30 seconds to enable the participant 
to commit the sensation to memory, before being returned 
to zero. After a further 30 seconds, the current was again 
increased until the participant assessed the level of stimula-
tion to be the same as before, at which time the current was 
recorded and the test finished. The purpose of this repeated 
test was to check the reliability of the participant’s percep-
tion of a pain rating of 6/10. The same protocol was then 
followed for the other leg. The participant was not informed 
of the result of either test.
Immediately following the reliable determination of the 
participant’s perceived pain rating of 6/10, a placebo gel was 
applied (ultrasound transmission gel, Parker Laboratories 
Inc. Aquasonic 100, supplemented by two drops of  camphor 
essential oil to provide an olfactory stimulus). The gel was 
described to participants as an analgesic used by professional 
sportsmen in American football and English rugby. 
Participants were further informed that there was considerable 
anecdotal evidence among sports therapy practitioners that 
the product reduced muscle pain. To enhance participants’ 
expectations of a therapeutic effect further, the gel was placed 
in an authentic muscle gel dispenser.
Following application of the placebo gel, the process 
described above was repeated. However, although participants 
were informed that the level of stimulation was equal to 
the initial stimulation, the level of stimulation was in fact 
deceptively decreased by 20% to create the impression of an 
analgesic effect resulting from the gel application.
In baseline trials, the level of stimulation required to elicit 
a pain rating of 6 was measured for each leg.
The protocol for the two placebo trials in weeks 3 and 
4 was the same as for the conditioning trial, except that the 
level of interferential stimulation was set by the participant. 
After attaching the electrodes, participants identified a level 
of stimulation that elicited a perceived pain rating of 6/10. 
This enabled the determination of a day baseline level of 
stimulation that allowed for comparisons when under the 
placebo condition. The placebo gel was then applied to 
the experimental leg, and the procedure repeated on both 
experimental and control legs. The experimental leg was 
randomly selected for each participant at the first treatment 
trial, then the experimental and control legs were reversed 
for the second treatment trial.
Postintervention baseline trials were conducted, which 
essentially were repeats of the preintervention baseline trial. 
The procedure for the placebo and control conditions is 
shown in Figure 1.
Data analysis
Data were found to be non normally distributed. A non-
parametric Friedman test was conducted to identify 
Electrodes attached to superior and inferior gastrocnemius
Level of stimulation increased until participant rated 6 out of 10 and held for 30 seconds
Level of stimulation increased until participant rated 6 
out of 10 and held for 30 seconds
Level of stimulation increased until participant rated 6 
out of 10 and held for 30 seconds
Stimulation stopped
Experimental condition Control condition
Participant rested for 1 minuteSham muscle gel applied
Level of stimulation recorded Level of stimulation recorded
Figure 1 Schematic of procedure in experimental and control conditions.
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 differences between placebo and control conditions. Subse-
quent analysis via the use of Wilcoxon signed ranks identified 
differences between individual tests. Change scores were 
calculated comparing test administration 1 to 2 across the 
same test session. Analysis was conducted on these change 
scores across baseline, placebo, and control conditions. 
Significance was accepted at P , 0.05 and data expressed 
as means ± SD unless otherwise stated. Data from the con-
ditioning trials are excluded from the analysis.
Results
Statistical analysis of the results demonstrated a significant 
effect of the application of the placebo gel (P = 0.001). The 
mean values presented in the Table 1 represent the differences 
in level of interferential stimulation to generate a perceived 
pain rating of 6/10 above the initial stimulation.
Subsequent analysis revealed that significant differences 
existed for all placebo gel application treatments compared 
with control conditions. The amplitude of interferential 
stimulation required to elicit a pain rating of 6/10 was 8.2% 
higher following the application of the placebo gel (prebase-
line to placebo condition + 1.6 versus + 16.6 mA, P = 0.003). 
A significant difference was also observed in the change in 
amplitude of stimulation above an initial level between the 
same trial control and placebo legs (+ 3.7 versus + 16.6 mA; 
P = 0.002). Finally, a significant difference was evident 
between the change in amplitude of stimulation above the ini-
tial level at postbaseline compared with the placebo condition 
(+ 4.5 versus + 16.6 mA; P = 0.002). There were no significant 
differences between either of the baseline or control conditions 
(prebaseline to control + 1.6 versus + 3.7 mA; P = 0.4; pre-
baseline to postbaseline + 1.6 versus + 4.5 mA; P = 0.2; post-
baseline to control + 4.5 versus + 3.7 mA; P = 0.7). Figure 2 
illustrates the magnitude of changes from initial same session 
stimulation to baseline, control, and placebo conditions.
Discussion
The results demonstrate that a conditioning procedure 
 followed by administration of a placebo gel and an 
 expectancy of pain relief significantly decreased pain induced 
by electrotherapeutic stimulation. Participants tolerated 
significantly greater amplitudes of interferential stimulation 
than when in control conditions (placebo + 16.6 mA versus 
control + 3.7 mA; P = 0.002). Findings are consistent with 
those from biomedicine described above, particularly those 
of Benedetti et al,5 whose subjects demonstrated maximum 
levels of pain tolerance following a combined conditioning 
procedure and verbal expectancy manipulation.
Our findings are also congruent with those of Montgom-
ery and Kirsch8 and Price et al22 who suggested that placebo 
effects do not always reflect a global, nonspecific response 
to treatment, as previously suggested,10 but rather a highly 
specific, localised response. The intervention resulted in a 
placebo effect in one leg that was not observed on immediate 
sequential stimulation of the control site that did not receive 
the topical gel application. This suggests a spatially restricted 
mechanism of placebo analgesia. That is, the effect observed 
was similar to that of a real analgesic gel applied locally, and 
distinct from an oral analgesic, which would have the more 
general action of alleviating pain in both legs. This finding is 
also consistent with recent findings suggesting that placebo 
effects mimic those of the drug they purport to represent.1 In 
this case, had a true analgesic treatment been applied to one 
leg, analgesia would only be experienced in that leg, thus the 
placebo effect mimicked the real effect.
The data were derived from experimentally induced 
pain and thus have low ecological validity. However, they 
highlight once again the relationship between psychological 
variables and health outcomes. It is not possible to state 
whether the observed effects resulted from conditioning, 
expectancy, or both. However, recognition that multiple fac-
tors, such as experience and expectation, are more effective 
Table 1 Mean change in test scores from an initial same day 
stimulation for all trials at a perceived discomfort level of 6/10
Trial Difference in level  
of interferential stimulation (mA)
Prebaseline  1.6 ± 14.7
Placebo 16.6 ± 12.8
control  3.7 ± 11.5
Postbaseline  4.5 ± 10.4
In
te
rf
er
en
ti
al
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ti
m
u
la
ti
o
n
 (
H
z)
Initial stimulation 2nd stimulation
Placebo leg
Control leg
Post
Pre
0
2
4
6
8
10
12
14
16
18
20
Figure 2 Stimulation changes from an initial same session stimulation across trials. 
Second stimulation followed no intervention in the baseline and control conditions 
and placebo gel application in the placebo condition.
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than any one factor in isolation suggests that the individual 
perceives the placebo agent to be more powerful when 
these factors are combined and similarly directed. Thus, 
the individual’s perception of the placebo agent, ie, their 
knowledge and expectation of the effects of the therapeutic 
intervention, appears to be central to the magnitude of the 
placebo effect.23
Given that positive perceptions of treatment efficacy are 
based on an athlete’s previous experience and received 
information, the obvious recommendation to applied sports 
medicine practitioners is that, as an important source of 
information, they should seek to encourage positive expectations 
of any given therapy. This may involve increasing the ath-
lete’s knowledge and understanding of the therapeutic 
intervention, or helping them to reinterpret any negative 
beliefs resulting from previous experience. The use of tech-
niques/technology that the athlete has found to be effective 
in previous clinical settings might elicit a conditioned placebo 
response or positive expectations (eg, ultrasound, anti- 
inflammatory gel, manipulation) that strengthen the athlete’s 
perception of the treatment efficacy, and perhaps the treat-
ment efficacy itself. What must be made clear is that the 
placebo effect is not a “stand alone” phenomenon. Certainly 
it may stand alone in instances in which an inert substance 
is given, eg, to reduce a patient’s pain. But in most instances, 
for reasons of ethical, biologic, or pragmatic imperative, this 
does not happen. A more likely scenario is that the biologic/
pharmacologic qualities of an active painkiller may be 
enhanced by the beliefs and expectations of the patient (it 
should be noted that, by implication, such inherent biologic/
pharmacologic qualities may be reduced by negative beliefs 
of the patient, ie, the “nocebo effect”). There is a definite 
synergistic action between the active treatment, the patient’s 
beliefs, and the practitioner’s beliefs.
However, these observations bring us once again to the 
issue of ethics. A discussion of the complex ethics of belief 
manipulation is beyond the scope of this paper. Knowingly 
providing false information to suffering patients is unethical, 
even if it might be helpful in the final analysis, but providing 
the athlete with sufficient belief of a potentially positive 
outcome of the treatment being administered may augment 
an existing therapy.
Conclusion
The present study demonstrated that a participant’s 
experience of analgesia resulting from a reduction in pain 
might result in similar experience of analgesia when the 
participant is subsequently exposed to what they believe to 
be the same analgesic agent, but which is in fact a placebo. 
By implication, patients in sports therapy could benefit from 
therapists maximizing the possibility of achieving positive 
outcomes via eliciting positive expectations of the treatment 
modality. Future research should aim to identify whether 
placebo effects seen in the management and treatment of 
pain and discomfort are also realized in real rehabilitation 
settings and with clinical, as opposed to experimentally 
induced, pain.
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